FDA to Host Public Meeting of Oncologic Drugs Advisory Committee and Seek Public Comments

Summary

The Food and Drug Administration (FDA) is hosting a public meeting of the Oncologic Drugs Advisory Committee (ODAC) to gather input on regulatory issues, and is seeking public comments on the matter. The meeting is open to the public and will be documented in a public docket.